CHD Bioscience, Inc.
Funding rounds
6 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jun 2025 | $1 M | No. 6 | Under $2 million | equity | SEC | |
| Jun 2018 | $2 M | No. 5 | Under $2 million | equity | SEC | |
| Feb 2017 | $3 M | No. 4 | $2 to $10 million | equity, options | SEC | |
| Jan 2016 | $3 M | No. 3 | $2 to $10 million | equity | SEC | |
| Mar 2015 | $2 M | No. 2 | Under $2 million | equity | SEC | |
| Feb 2014 | $3 M | No. 1 | $2 to $10 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
CHD Bioscience, Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2025).
SEC Form D · Jul 2025
The industry group it chose in its notices: Other.
SEC Form D · Jul 2025
That is all the official record says: CHD Bioscience, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of CHD Bioscience, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 6 rounds above had up to 20 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Michael Voss | Executive officer | Jul 2025 |
| Steve Coder | Executive officer | Jul 2025 |
| Dennis Templar | Executive officer | Sep 2018 |
| Robert Kali | Executive officer | Sep 2018 |
| Ted Ziemann | Executive officer | Sep 2018 |
| Ed Neas | Executive officer | Nov 2017 |
| Michael Handley | Executive officer | Nov 2017 |
| Alan Ruud | Director | Jul 2025 |
| Alan Smith, Ph.D. | Director | Jul 2025 |
| Christopher Rudd | Director | Jul 2025 |
| Michael Litwack | Director | Jul 2025 |
| Michael Voss | Director | Jul 2025 |
| Steve Coder | Director | Jul 2025 |
| Theodore Ziemann | Director | Jul 2025 |
| William Nelson, MD, Ph.D. | Director | Jul 2025 |
| Alan Smith | Director | Sep 2018 |
| Dennis Templar | Director | Sep 2018 |
| Ed Neas | Director | Sep 2018 |
| Stephen Coder | Director | Sep 2018 |
| Ted Ziemann | Director | Sep 2018 |
| William Nelson | Director | Sep 2018 |
| Michael Handley | Director | Nov 2017 |
| Loretta Mealy | Director | Jun 2016 |
| Roy Carver, Jr. | Director | Jun 2016 |
| William Nelson, V | Director | Jun 2016 |
| Doug Coder | Director | Feb 2016 |
| Roy, Jr. Carver | Director | Feb 2016 |
| Cathy Sohn | Director | Apr 2014 |